Literature DB >> 16257206

Derivatives of tramadol for increased duration of effect.

Liming Shao1, Craig Abolin, Michael C Hewitt, Patrick Koch, Mark Varney.   

Abstract

Tramadol is a centrally acting opioid analgesic structurally related to codeine and morphine. Analogs of tramadol with deuterium-for-hydrogen replacement at metabolically active sites were prepared and evaluated in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16257206     DOI: 10.1016/j.bmcl.2005.10.024

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  6 in total

1.  Kinetic Deuterium Isotope Effects in Cytochrome P450 Reactions.

Authors:  Frederick P Guengerich
Journal:  Methods Enzymol       Date:  2017-07-18       Impact factor: 1.600

2.  Design, synthesis and biological evaluation of N-phenylalkyl-substituted tramadol derivatives as novel μ opioid receptor ligands.

Authors:  Qing Shen; Yuan-yuan Qian; Xue-jun Xu; Wei Li; Jing-gen Liu; Wei Fu
Journal:  Acta Pharmacol Sin       Date:  2015-06-08       Impact factor: 6.150

3.  5'-Phosphate and 5'-phosphonate ester derivatives of (N)-methanocarba adenosine with in vivo cardioprotective activity.

Authors:  T Santhosh Kumar; Tiehong Yang; Shilpi Mishra; Chunxia Cronin; Saibal Chakraborty; Jian-Bing Shen; Bruce T Liang; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2013-01-22       Impact factor: 7.446

4.  The first structure-activity relationship studies for designer receptors exclusively activated by designer drugs.

Authors:  Xin Chen; Hyunah Choo; Xi-Ping Huang; Xiaobao Yang; Orrin Stone; Bryan L Roth; Jian Jin
Journal:  ACS Chem Neurosci       Date:  2015-01-27       Impact factor: 4.418

5.  Relevance of Hydrogen Bonds for the Histamine H2 Receptor-Ligand Interactions: A Lesson from Deuteration.

Authors:  Mojca Kržan; Jan Keuschler; Janez Mavri; Robert Vianello
Journal:  Biomolecules       Date:  2020-01-29

6.  Effect of N-methyl deuteration on metabolism and pharmacokinetics of enzalutamide.

Authors:  Jinfang Jiang; Xuehai Pang; Liang Li; Xiaojian Dai; Xingxing Diao; Xiaoyan Chen; Dafang Zhong; Yingwei Wang; Yuanwei Chen
Journal:  Drug Des Devel Ther       Date:  2016-07-07       Impact factor: 4.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.